AMERICAN COASTAL INSURANCE Corp (ACIC): Results of Operations and Financial Condition

American Coastal Insurance (NASDAQ:ACIC) reported first-half 2025 net income of $41M, down from $48M a year earlier, with annualized ROE at 25%. The company expects to launch its E&S carrier, ACES, in Q2 2027, targeting Florida, Texas, and South Carolina. American Coastal also expanded its reinsurance program, securing $1.7B in catastrophe coverage for 2026-2027. The company's stockholders' equity increased to $341M by June 30, 2025, and it plans to refinance half of its $150M debt maturing in 2

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

Eli Lilly (LLY) reports that Foundayo, its oral GLP-1 drug, now accounts for about one-third of new patients starting the treatment. Foundayo generated $98 million in Q2 revenue, contributing to Lilly's total Q2 revenue of $23.0 billion, up 48% YoY. Lilly raised its 2026 revenue guidance to $85 billion-$87 billion and is investing $6.5 billion in a new Houston facility to produce Foundayo and other medicines.

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.

Samsung Electronics forecasts Q3 revenue of ₩200.279 trillion and operating profit of ₩106.9887 trillion, more than double last year's annual profit. The memory division, particularly DRAM and NAND, is driving this growth, with price increases and high profitability. HBM4 mass production is boosting competitiveness, while non-memory sectors face deficits.